LX

LXEO

Lexeo Therapeutics, Inc. - Common Stock

NASDAQ
Market Cap
P/E Ratio
52.00
Dividend Yield
0.00%
Volume
52W High
52W Low
Avg Volume
52W Range

Financial Statements

What does this mean?

Income statement, balance sheet, and cash flow over time

Metric
No financial data available

Institutional Ownership

What does this mean?

Top institutions holding LXEO

Institution Shares Held Value Date
Vanguard Group 150,000,000 $25,000,000,000 Oct 2025
BlackRock 140,000,000 $23,500,000,000 Sep 2025
State Street 80,000,000 $13,500,000,000 Sep 2025
Fidelity 65,000,000 $11,000,000,000 Nov 2025
Geode Capital 35,000,000 $5,900,000,000 Oct 2025

Top ETFs holding LXEO

ETF Weight Shares
QQQ 8.50% 24,782,676
VGT 6.20% 5,509,185
SPY 4.50% 27,179,926
IVV 4.20% 22,947,980
VOO 3.80% 20,395,905

Frequently Asked Questions

Common questions about LXEO

Lexeo Therapeutics, Inc. - Common Stock (LXEO) is a publicly traded company listed on NASDAQ. Lexeo Therapeutics, Inc. - Common Stock (LXEO) is included in the Stock Monitor database for research and watchlists.

The current stock price of LXEO is $249.00, with a change of +0.00% in the latest session. Stock prices are updated during market hours and may be delayed.

LXEO does not currently pay regular dividends. Many growth companies choose to reinvest earnings into the business rather than distribute them as dividends.

The P/E (Price-to-Earnings) ratio of LXEO is 52.00. This relatively high P/E may indicate growth expectations or that the stock is trading at a premium. The P/E ratio compares the stock price to earnings per share and is commonly used for valuation.

LXEO has a market capitalization of $1.60 trillion, making it a mega-cap company. Market cap is calculated by multiplying the current stock price by the total number of outstanding shares.

The 52-week trading range for LXEO is $161.85 (low) to $273.90 (high). This range represents the lowest and highest prices the stock has traded at over the past year.

Trade

Buy/Sell via broker links (affiliate).

Trading 212
Open Broker
Links may be affiliate links. Trading involves risk.

Paper Trade

Save a buy/sell to your portfolio tracker (not a real trade).

Sign in to save trades to your portfolio tracker.

Paper Orders

Limit/stop reminders, with optional bracket (take profit + stop loss).

Sign in to place paper orders.

Price Alerts

Notify when LXEO crosses your target.

Sign in to create alerts and sync them across devices.

About

Lexeo Therapeutics, Inc. - Common Stock (LXEO) is included in the Stock Monitor database for research and watchlists.

CEO
N/A
Employees
25,400
IPO Date
Jan 1, 2000

Analyst Ratings

What does this mean?
JPMorgan
Dec 3, 2025
Hold
Bernstein
Nov 16, 2025
Hold
Piper Sandler
Oct 30, 2025
Overweight
Goldman Sachs
Oct 8, 2025
Buy
Morgan Stanley
Sep 21, 2025
Buy
Price Target
$293.82